GLP-1 Receptor Agonists Induce Growth Hormone Secretion in Healthy Volunteers

被引：0
|
作者：
Keiu Heinla
Eero Vasar
Ingrid Reppo
Tuuli Sedman
Vallo Volke
机构：
[1] University of Tartu,Department of Physiology, Institute of Biomedicine and Translational Medicine, Centre of Excellence in Genomics and Translational Medicine
[2] Tartu University Hospital,Endocrinology Unit
[3] Tartu University Hospital,Psychiatry Clinic
来源：
Diabetes Therapy | 2023年 / 14卷
关键词：
Exenatide; GLP-1 receptor agonist; Growth hormone;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：777 / 786
页数：9
相关论文
共 50 条
  • [21] GLP-1 Receptor Agonists and Kidney Protection
    Greco, Eulalia Valentina
    Russo, Giuseppina
    Giandalia, Annalisa
    Viazzi, Francesca
    Pontremoli, Roberto
    De Cosmo, Salvatore
    MEDICINA-LITHUANIA, 2019, 55 (06):
  • [22] GLP-1 receptor agonists and cardiovascular safety
    Huang, Yu-Yao
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2016, 120 : S20 - S20
  • [23] The Cautious Promise of GLP-1 Receptor Agonists
    Dauterive, Rachel S.
    OCHSNER JOURNAL, 2024, 24 (03): : 165 - 166
  • [24] GLP-1 and dual GIP/GLP-1 receptor agonists increase risk of aspiration
    Reactions Weekly, 2025, 2044 (1) : 3 - 3
  • [25] Effect of Biased GLP-1/Glucagon Receptor Co-agonists on Insulin Secretion
    Farooq, Gala
    Jones, Ben
    Minnion, James S.
    Bloom, Stephen R.
    DIABETES, 2018, 67
  • [26] The stimulation of GLP-1 secretion and delivery of GLP-1 agonists &ITvia&IT nanostructured lipid carriers
    Shrestha, Neha
    Bouttefeux, Oriane
    Vanvarenberg, Kevin
    Lundquist, Patrik
    Cunarro, Juan
    Tovar, Sulay
    Khodus, Georgiy
    Andersson, Ellen
    Keita, Asa V.
    Dieguez, Carlos Gonzalez
    Artursson, Per
    Preat, Veronique
    Beloqui, Ana
    NANOSCALE, 2018, 10 (02) : 603 - 613
  • [27] The Impact of GLP-1 Receptor Agonists (GLP-1 RAs) on Mental Health: A Systematic Review
    Silvia Tempia Valenta
    Alba Nicastri
    Federica Perazza
    Federica Marcolini
    Valentina Beghelli
    Anna Rita Atti
    Maria Letizia Petroni
    Current Treatment Options in Psychiatry, 2024, 11 (4) : 310 - 357
  • [28] Mechanisms of action and therapeutic applications of GLP-1 and dual GIP/GLP-1 receptor agonists
    Liu, Qiyuan Keith
    FRONTIERS IN ENDOCRINOLOGY, 2024, 15
  • [29] GLP-1 RECEPTOR VARIANTS MARKEDLY DIFFERENTIATE GLYCAEMIC RESPONSE TO GLP-1 RECEPTOR AGONISTS: A DIRECT STUDY
    Dawed, A. Y.
    Mari, A.
    McDonald, T. J.
    Hong, M. -G
    Sharma, S.
    Robertson, N. R.
    Mahajan, A.
    Walker, M.
    Gough, S.
    Zhou, K.
    Forgie, I
    Ruetten, H.
    Jones, A. G.
    Pearson, E. R.
    BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY, 2018, 123 : 13 - 14
  • [30] GLP-1 receptor variants markedly differentiate glycaemic response to GLP-1 receptor agonists: a DIRECT study
    Dawed, A. Y.
    Mari, A.
    McDonald, T. J.
    Hong, M. G.
    Sharma, S.
    Robertson, N. R.
    Mahajan, A.
    Walker, M.
    Gough, S.
    Zhou, K.
    Forgie, I.
    Ruetten, H.
    Jones, A. G.
    Pearson, E. R.
    DIABETOLOGIA, 2017, 60 : S393 - S393
12345